Pfizer Strikes $10 Billion Agreement to Acquire Metsera
The American pharmaceutical titan Pfizer will purchase Metsera, a company that develops therapies for obesity, for $10 billion. Pfizer won a two-month acquisition battle with Danish pharmaceutical company Novo Nordisk, gaining a foothold for entrance into the quickly expanding obesity medicine market. The Biotech War Between Novo and Pfizer Pfizer had been seen as … Read more